Clinton Health Access Initiative, Nigeria   Report issue

Foundation Phase 2 Phase 3
Founded: New York NY Nigeria (2002)

Organization Overview

First Clinical Trial
2015
NCT02315690
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

Clinton Health Access Initiative Inc. | Clinton Health Access Initiative, Nigeria

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Malaria (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 7